Literature DB >> 6272967

Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by clinical, virological, and immunopathological studies.

D T Purtilo, K Sakamoto, A K Saemundsen, J L Sullivan, A C Synnerholm, M Anvret, J Pritchard, C Sloper, C Sieff, J Pincott, L Pachman, K Rich, F Cruzi, J A Cornet, R Collins, N Barnes, J Knight, B Sandstedt, G Klein.   

Abstract

Multiple methods, pedigree analysis, clinical evaluation, and Epstein-Barr virus (EBV)-specific serology, EBV DNA hybridization of tissues to probe for viral genome, staining of touch imprints for EBV nuclear-associated antigen, establishment of spontaneous infected B-cell lines from peripheral blood or tissues, examination of peripheral blood smears, and hematopathology studies, were used to study seven patients with the X-linked lymphoproliferative syndrome and seven additional patients with life-threatening EBV-associated diseases. These studies demonstrated EBV in the tissues of all 14 patients and immunodeficient antibody responses to EBV were documented. This virus can produce various life-threatening lymphoproliferative diseases in a variety of immunodeficient patients.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6272967

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

1.  Virus-associated haemophagocytic syndrome with Epstein-Barr virus infection.

Authors:  K Ohshima; M Kikuchi; F Eguchi; S Kobari; H Tasaka
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

2.  Increased frequency of antibodies to ubiquitous viruses in essential mixed cryoglobulinaemia.

Authors:  G Fiorini; P Bernasconi; R A Sinico; R Chianese; F Pozzi; G D'Amico
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

3.  Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas.

Authors:  A A Brink; D F Dukers; A J van den Brule; J J Oudejans; J M Middeldorp; C J Meijer; M Jiwa
Journal:  J Clin Pathol       Date:  1997-11       Impact factor: 3.411

4.  Stress and the transformation of lymphocytes by Epstein-Barr virus.

Authors:  J K Kiecolt-Glaser; C E Speicher; J E Holliday; R Glaser
Journal:  J Behav Med       Date:  1984-03

Review 5.  Epstein-Barr virus (EBV), lymphocytes and transformation.

Authors:  J Zeuthen
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

6.  Varicella-zoster virus as a live vector for the expression of foreign genes.

Authors:  R S Lowe; P M Keller; B J Keech; A J Davison; Y Whang; A J Morgan; E Kieff; R W Ellis
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

Review 7.  Epstein-Barr virus infection and associated diseases in children. II. Diagnostic and therapeutic strategies.

Authors:  V Schuster; H W Kreth
Journal:  Eur J Pediatr       Date:  1992-11       Impact factor: 3.183

8.  Increased expression of Epstein-Barr virus in primary biliary cirrhosis patients.

Authors:  S A Morshed; M Nishioka; I Saito; K Komiyama; I Moro
Journal:  Gastroenterol Jpn       Date:  1992-12

Review 9.  Epstein-Barr virus infection and associated diseases in children. I. Pathogenesis, epidemiology and clinical aspects.

Authors:  V Schuster; H W Kreth
Journal:  Eur J Pediatr       Date:  1992-10       Impact factor: 3.183

10.  Immunohistology of the thymus in bone marrow transplant recipients.

Authors:  J A Thomas; J P Sloane; S F Imrie; M A Ritter; H J Schuurman; J Huber
Journal:  Am J Pathol       Date:  1986-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.